4.Progress in autoimmune liver diseases.
Hong YOU ; Ya-meng SUN ; Ji-dong JIA
Chinese Journal of Hepatology 2013;21(2):87-89
Autoimmune Diseases
;
diagnosis
;
genetics
;
therapy
;
Humans
;
Liver Diseases
;
diagnosis
;
genetics
;
therapy
6.Proteomic Approach in Gastrointestinal and Liver Research.
Marie YEO ; Sung Won CHO ; Ki Baik HAHM
The Korean Journal of Gastroenterology 2004;44(5):239-245
In the post-genomic era, the focus of research is now moving to functional genomics employing the information on predicted gene products provided by genome sequencing. Proteomics, the global analysis of structures, functions, and interactions of whole cellular proteins, draws the special attention as a tool for documenting the disease pathogenesis or progression. The high-throughput technology has become feasible by considerable improvement of two dimensional electrophoresis and mass fingerprinting. Thus proteome techniques can be used as tools to study the disease processes, develop new biomakers for diagnosis and early detection of diseases, and accelerate drug development. In this review, we discuss the background and techniques of proteomics, and potential applications to the research of gastrointestinal diseases.
English Abstract
;
*Gastrointestinal Diseases/diagnosis/therapy
;
Humans
;
*Liver Diseases/diagnosis/therapy
;
*Proteomics
8.Guidelines on the management of cholestasis liver diseases (2021).
Chinese Journal of Hepatology 2022;30(3):253-263
In 2015, the Chinese Society of Hepatology and Chinese Society of Gastroenterology issued the consensus on the diagnosis and management of cholestatic liver diseases. In the past years, more data have emerged from clinical practice. Herein, the Autoimmune Liver Disease Group of the Chinese Society of Hepatology organized an expert group to review the evidence and updated the recommendations to formulate the guidelines. There are 22 recommendations on clinical practice of cholestatic liver diseases. The guidelines aim to provide a working reference for the management of cholestatic liver diseases.
Autoimmune Diseases/diagnosis*
;
Cholestasis/therapy*
;
Consensus
;
Gastroenterology
;
Humans
;
Liver Diseases/therapy*
9.Update hepatology in 2008.
Chinese Journal of Hepatology 2009;17(1):1-4
Carcinoma, Hepatocellular
;
diagnosis
;
therapy
;
Gastroenterology
;
trends
;
Hepatitis, Viral, Human
;
diagnosis
;
therapy
;
Humans
;
Liver Cirrhosis
;
diagnosis
;
therapy
;
Liver Diseases
;
diagnosis
;
therapy
;
Liver Failure, Acute
;
etiology
;
therapy
;
Liver Neoplasms
;
diagnosis
;
therapy
;
Retrospective Studies
10.A case of primary hepatic actinomycosis.
Jeong Deuk LEE ; Pan Gyu KIM ; Hyeon Mi JO ; Doo Ho PARK
Journal of Korean Medical Science 1993;8(5):385-389
Actinomycosis is a chronic suppurative and granulomatous disease characterized histologically by sulfur granules with extensive necrosis, fibrosis and sinus formation. Depending on the site of primary infection, actinomycosis is generally classified as cervicofacial, thoracic and abdominal type. The liver is known to be the primary site of infection in 15% with abdominal actinomycosis. The authors have experienced a case of liver abscess in a 24-year-old male. The sono-guided aspiration biopsy revealed findings of infiltration of neutrophils and characteristics sulfur granules by light microscopy. This case was thought to represent an instance of liver actinomycosis. Although there have been a lot of reports on actinomycosis of the liver in other countries, only 3 cases were reported in Korea.
Actinomycosis/*diagnosis/drug therapy
;
Adult
;
Humans
;
Liver Diseases/*diagnosis/drug therapy
;
Male